首页> 美国卫生研究院文献>Journal of Applied Clinical Medical Physics >Direct machine parameter optimization for intensity modulated radiation therapy (IMRT) of oropharyngeal cancer – a planning study
【2h】

Direct machine parameter optimization for intensity modulated radiation therapy (IMRT) of oropharyngeal cancer – a planning study

机译:口咽癌调强放射治疗(IMRT)的直接机器参数优化–规划研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of the study was to investigate the potential of direct machine parameter optimization (DMPO) to achieve parotid sparing without compromising target coverage in IMRT of oropharyngeal cancer as compared to fluence modulation with subsequent leaf sequencing (IM) and forward planned two‐step arc therapy (IMAT). IMRT plans were generated for 10 oropharyngeal cancer patients using DMPO and IM. The resulting dose volume histograms (DVH) were evaluated with regard to compliance with the dose volume objectives (DVO) and plan quality. DMPO met the DVO for the targets better than IM, but violated the DVO to the parotids in some cases. DMPO provided better target coverage and dose homogeneity than IM and was comparable to IMAT. Dose to the parotids (23Gy) was significantly lower than for IMAT (48Gy), but somewhat higher than for IM (20Gy). Parotid sparing with IM was, however, only achieved at the cost of target coverage and homogeneity. DMPO allows achieving parotid sparing in the treatment of oropharyngeal cancer without compromising target coverage and dose homogeneity in the target as compared to two‐step IMAT. Better overall plan quality can be delivered with less monitor units than with IM.PACS number: 87.50.Gi
机译:这项研究的目的是研究与通过后续叶序测序(IM)和前瞻性计划两步弧线进行能量通量调制相比,直接机器参数优化(DMPO)在不影响口咽癌IMRT目标覆盖率的情况下实现腮腺保护的潜力治疗(IMAT)。使用DMPO和IM为10例口咽癌患者制定了IMRT计划。评估剂量体积直方图(DVH)是否符合剂量体积目标(DVO)和计划质量。 DMPO达到DVO的目标要比IM更好,但在某些情况下违反了腮腺DVO。 DMPO比IM提供了更好的靶标覆盖范围和剂量均一性,与IMAT相当。腮腺的剂量(23G​​y)明显低于IMAT(48Gy),但略高于IM(20Gy)。然而,IM腮腺保留仅以靶标覆盖和同质性为代价。与两步IMAT相比,DMPO可以在口咽癌治疗中实现腮腺保护,而不会损害靶标覆盖率和靶标剂量均一性。与IM.PACS编号:87.50.Gi相比,使用更少的监控器可以提供更好的总体计划质量

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号